Ping-Ping Bao1, Gen-Ming Zhao, Xiao-Ou Shu, Peng Peng, Hui Cai, Wei Lu, Ying Zheng. 1. From the aDepartment of Epidemiology, School of Public Health, Fudan University, Shanghai, People's Republic of China; bDepartment of Cancer Control & Prevention, Shanghai Municipal Center for Disease Control & Prevention, Shanghai, People's Republic of China; and cDivision of Epidemiology, Department of Medicine and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Vanderbilt University, Nashville, TN.
Abstract
BACKGROUND: Very little is known about the effect of modifiable lifestyle factors on outcomes of triple-negative breast cancer. We examined this association in a population-based prospective cohort study of patients with triple-negative breast cancer. METHODS: A total of 518 women with confirmed triple-negative breast cancer, recruited by the Shanghai Breast Cancer Survival Study, completed 6-, 18-, 36-, and 60-month postdiagnosis surveys. We applied Cox proportional hazard models to evaluate the associations. RESULTS: The mean age at diagnosis was 53.4 (standard deviation = 10.6) years old. After a median follow-up of 9.1 years (range: 0.6-11.8), 128 deaths and 112 recurrences were documented. Exercise during the first 60 months postdiagnosis was inversely associated with total mortality and recurrence/disease-specific mortality with adjusted hazard ratios (HRs) of 0.67 (95% confidence interval [CI] = 0.46, 0.96) and 0.58 (95% CI = 0.39, 0.86), respectively. Women with higher exercise-metabolic equivalent scores (≥7.6 metabolic equivalent-hours/week) and longer duration of exercise (≥2.5 hours/week) had lower risk of total and recurrence/disease-specific mortality than did nonexercisers. Compared with nontea drinkers, survival was better among women who were regular tea drinkers during the first 60 months for all cause (HR = 0.57, 95% CI = 0.34, 0.93) and recurrence/disease-specific mortality (HR = 0.54, 95% CI = 0.31, 0.96). There was no dose-response pattern for tea consumption. No interactions were observed for body mass index, menopausal status, and comorbidity. CONCLUSIONS: These findings show that postdiagnosis exercise and tea intake were associated with improved survival among women with triple-negative breast cancer.
BACKGROUND: Very little is known about the effect of modifiable lifestyle factors on outcomes of triple-negative breast cancer. We examined this association in a population-based prospective cohort study of patients with triple-negative breast cancer. METHODS: A total of 518 women with confirmed triple-negative breast cancer, recruited by the Shanghai Breast Cancer Survival Study, completed 6-, 18-, 36-, and 60-month postdiagnosis surveys. We applied Cox proportional hazard models to evaluate the associations. RESULTS: The mean age at diagnosis was 53.4 (standard deviation = 10.6) years old. After a median follow-up of 9.1 years (range: 0.6-11.8), 128 deaths and 112 recurrences were documented. Exercise during the first 60 months postdiagnosis was inversely associated with total mortality and recurrence/disease-specific mortality with adjusted hazard ratios (HRs) of 0.67 (95% confidence interval [CI] = 0.46, 0.96) and 0.58 (95% CI = 0.39, 0.86), respectively. Women with higher exercise-metabolic equivalent scores (≥7.6 metabolic equivalent-hours/week) and longer duration of exercise (≥2.5 hours/week) had lower risk of total and recurrence/disease-specific mortality than did nonexercisers. Compared with nontea drinkers, survival was better among women who were regular tea drinkers during the first 60 months for all cause (HR = 0.57, 95% CI = 0.34, 0.93) and recurrence/disease-specific mortality (HR = 0.54, 95% CI = 0.31, 0.96). There was no dose-response pattern for tea consumption. No interactions were observed for body mass index, menopausal status, and comorbidity. CONCLUSIONS: These findings show that postdiagnosis exercise and tea intake were associated with improved survival among women with triple-negative breast cancer.
Authors: John P Pierce; Ruth E Patterson; Carolyn M Senger; Shirley W Flatt; Bette J Caan; Loki Natarajan; Sarah J Nechuta; Elizabeth M Poole; Xiao-Ou Shu; Wendy Y Chen Journal: J Natl Cancer Inst Date: 2013-12-07 Impact factor: 13.506
Authors: Marilyn L Kwan; Wendy Y Chen; Shirley W Flatt; Erin K Weltzien; Sarah J Nechuta; Elizabeth M Poole; Michelle D Holmes; Ruth E Patterson; Xiao Ou Shu; John P Pierce; Bette J Caan Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-11-13 Impact factor: 4.254
Authors: Sharon K Sagiv; Mia M Gaudet; Sybil M Eng; Page E Abrahamson; Sumitra Shantakumar; Susan L Teitelbaum; Julie A Britton; Paula Bell; Joyce A Thomas; Alfred I Neugut; Regina M Santella; Marilie D Gammon Journal: Ann Epidemiol Date: 2007-03-28 Impact factor: 3.797
Authors: Meng-Hua Tao; Pierre Hainaut; Catalin Marian; Jing Nie; Christine Ambrosone; Stephen B Edge; Maurizio Trevisan; Joan Dorn; Peter G Shields; Jo L Freudenheim Journal: Cancer Causes Control Date: 2013-09-26 Impact factor: 2.506
Authors: Xifeng Wu; Yuanqing Ye; Carlos H Barcenas; Wong-Ho Chow; Qing H Meng; Mariana Chavez-MacGregor; Michelle A T Hildebrandt; Hua Zhao; Xiangjun Gu; Yang Deng; Elizabeth Wagar; Francisco J Esteva; Debu Tripathy; Gabriel N Hortobagyi Journal: J Natl Cancer Inst Date: 2017-07-01 Impact factor: 13.506
Authors: Mark W Dewhirst; Lee W Jones; Victoria Seewaldt; Oliver K Glass; Michelle Bowie; Julie Fuller; David Darr; Jerry Usary; Keara Boss; Kingshuk Roy Choudhury; Xioajing Liu; Zoe Zhang; Jason W Locasale; Christina Williams Journal: Oncotarget Date: 2017-09-19
Authors: M Pollán; S Casla-Barrio; J Alfaro; C Esteban; M A Segui-Palmer; A Lucia; M Martín Journal: Clin Transl Oncol Date: 2020-02-13 Impact factor: 3.405
Authors: Tarun K K Mamidi; Jiande Wu; Paul B Tchounwou; Lucio Miele; Chindo Hicks Journal: Int J Environ Res Public Health Date: 2018-10-23 Impact factor: 3.390